Cambridge Healthtech Institute’s Sixth Annual

Circulating Tumor Cells

Enabling Liquid Biopsy

March 7 – 9, 2016 | Moscone North Convention Center | San Francisco, CA
Part of the 23rd International Molecular Medicine Tri-Conference


Many technologies have been developed for the application of circulating tumor cells, including techniques for isolation, enumeration, characterization, propagation and genomic profiling. However, as yet there is only one approved technology for clinical use. This year’s Sixth Annual Circulating Tumor Cells conference will delve into new insights in the field of circulating tumor cell research and clinical application by investigating key challenges for advancement into the clinic. The visionary faculty will look at comparisons of technical progress and advancement for a range of circulating biomarkers including cell-free DNA, exosomes and extracellular vesicles and illuminate strategies for moving them into clinical use.

Who should attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in fields of R&D, Oncology, Cell Biology, Chemistry and Biotechnology.

Topics will include, but are not limited to: 

  • Platelet cloaking of CTCs and cancer
  • Circulating RNA and DNA
  • Novel findings with capturing tumor-specific exosomes and extracellular vesicles
  • Pros and cons of circulating tumor cells vs. circulating DNA
  • Clinical applications and results
  • Functional analysis of CTCs
  • Propagating cells in vitro
  • Mouse models to test new technologies
  • Creating a genomic snapshot of cancer

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is August 7, 2015. 

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

For more details on the conference, please contact:
Christina Lingham
Executive Director, Conferences
Cambridge Healthtech Institute
T: 781-972-5464

For partnering and sponsorship information, please contact:
Jon Stroup (Companies A-K)
Senior Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483

Joseph Vacca (Companies L-Z)
Associate Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431

Premier Sponsors:   


Jackson Laboratory - small logo  


 Precision for Medicine 


Silicon Biosystems 

Thomson Reuters-Large